U
Targeted Medical Pharma, Inc. TRGM
$0.00 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

12/31/2015 09/30/2015 06/30/2015 03/31/2015 12/31/2014
Net Income 60.80% 76.54% -29.06% -72.23% -398.31%
Total Depreciation and Amortization -45.30% -47.89% -42.23% -35.52% -4.77%
Total Amortization of Deferred Charges 12.97% -28.61% -19.01% -33.36% 0.00%
Total Other Non-Cash Items -26.33% -112.26% -632.26% -87.24% 686.11%
Change in Net Operating Assets -71.50% -65.26% -33.43% -90.47% 153.45%
Cash from Operations -67.82% -29.87% -106.02% -1,820.37% 112.67%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- 344.44% -344.44% --
Cash from Investing -- -- 344.44% -344.44% --
Total Debt Issued -- -100.00% -- -- -100.00%
Total Debt Repaid 57.04% 56.12% 63.91% 69.22% 48.22%
Issuance of Common Stock -- -- -- -- -100.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 94.56% 23.17% 63.91% 620.29% -112.20%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 315.28% -105.19% -199.41% 152.96% -108.89%
Weiss Ratings